AI assistant
MAXCYTE, INC. — Director's Dealing 2025
Aug 27, 2025
10520_dirs_2025-08-27_47cefd72-148d-41f0-a21c-03775768d18c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MAXCYTE, INC. (MXCT)
CIK: 0001287098
Period of Report: 2025-06-25
Reporting Person: Hemrajani Rekha (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-25 | Common Stock | S | 10684 | $2.0945 | Disposed | 39893 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2025.
F2: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.07 to $2.1212, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.